Selektope (Sweden)
13 Mar 2018 11:19 (GMT+1)

I-Tech AB strengthens Selektope® supply chain with strategic acquisition

Selektope: Swedish bio-technology company I-Tech AB has today announced the strategic acquisition of manufacturing process technology and IP, for the production of medetomidine, from Cambrex Corporation (NYSE: CBM). The transaction consolidates the supply chain and improves I-Tech’s industrial capabilities. I-Tech AB has registered and patented medetomidine as a marine antifouling agent and is offering the active substance under the registered trademark Selektope® to the global marine co...
Login or Signup to read the full article
3

Related Articles

Comments

This post has been shared in your feed.

View Post

Not a member yet? To access you will need to login or signup

OceanHub is the Ocean Space knowledge community, where you can:

  • Increase your ocean knowledge, influence and network
  • Connect with ocean users, groups, brands and much more
  • Have a profile, newsfeed and access to read and post articles
To read articles you will need to
signup or login.
It's totally free!
By signing up, you agree to our terms of service and privacy policy